| Literature DB >> 32210926 |
Amal A Elkhawaga1, Helal F Hetta1,2, Naglaa S Osman3, Amal Hosni4, Mohamed A El-Mokhtar1.
Abstract
BACKGROUND AND AIM: Cronobacter sakazakii (C. sakazakii) has attracted considerable attention as an emerging neonatal pathogen and has been associated with outbreaks of life-threatening septicemia, necrotizing enterocolitis, and meningitis in neonates and infants globally. No data about the role of C. sakazakii as a cause of neonatal sepsis in North Africa is availale. Herein, we aimed to study the incidence of C. sakazakii in cases of neonatal sepsis, its distribution in different food samples in Egypt, antimicrobial profile, and the ability of the strains to form biofilms.Entities:
Keywords: C. sakazakii; PCR; herbs; powdered infant formula; septicemia
Year: 2020 PMID: 32210926 PMCID: PMC7075355 DOI: 10.3389/fmicb.2020.00215
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Demographic and clinical data of the study population.
| Variable | Number of cases (%) |
| Male gender | 67 (67%) |
| Birth weight (g) | |
| Median (range) | 2,000 (1,000–3,000) |
| Residence | |
| Rural | 78 (78%) |
| Urban | 22 (22%) |
| Cesarian section | 83 (83%) |
| Low Apgar score at 1 min | 33 (33%) |
| Low Apgar score at 5 min | 12 (12%) |
| Central line insertion | 97 (97%) |
| Maternal risk factors | |
| Preeclampsia | 8 (8%) |
| Premature rupture of membranes | 5 (5%) |
| Fever | 7 (7%) |
| Antepartum hemorrhage | 2 (2%) |
| Clinical manifestations | |
| Poor oral intake | 77 (77%) |
| Fever >37.8°C | 87 (87%) |
| Hypothermia <36°C | 13 (13%) |
| Jaundice | 31 (31%) |
| Eye discharge | 9 (9%) |
| Skin rash | 11 (11%) |
| Respiratory distress | 88 (88%) |
| Apnea | 19 (19%) |
| Pneumonia | 33 (33%) |
| Diarrhea | 28 (28%) |
| Elevated CRP | 100 (100%) |
| Total leukocytic count (cells/μl) | |
| Mean ± SD | 22.97 ± 11.38 |
| Median (range) | 23.85 (2.9–49.0) |
| Absolute neutrophilic count (<1,000 cells/μl) | 8 (8%) |
| Platelet count (<100 cells/μl) | 23 (23%) |
FIGURE 1Morphological appearance of Cronobacter sakazakii colonies. Samples were inoculated on (A) Brilliance C. sakazakii chromogenic agar showing greenish colonies; (B) blood agar showing non-hemolytic colonies; (C) trypticase soya agar (TSA) showing flat yellow colonies; and (D) MacConkey agar showing pink lactose-fermenting colonies. Plates were incubated for 24 h at 36°C, except for trypticase soya agar which was incubated at 25°C. TSA was not supplied with 5% sheep blood.
Prevalence of Cronobacter sakazakii in the analyzed samples.
| Types of samples | Number of |
| Blood cultures | 12/100(12%) |
| Powdered infant formula (PIF) | 70/400(17.5%) |
| From neonatal ICU | 46/200(23%) |
| Used PIF containers | 21/100(21%) |
| Unopened PIF containers | 3/100(3%) |
| Herbs | 46/500(9.2%) |
| Anise | 17/50(26%) |
| Licorice | 13/50(34%) |
| Green tea | 4/50(8%) |
| Mint | 4/50(8%) |
| Fenugreek | 0/50(0%) |
| Caraway | 2/50(4%) |
| Herbal tea | 5/50(10%) |
| Hibiscus | 0/50(0%) |
| Chamomile | 1/50(2%) |
| Thyme | 0/50(0%) |
| Water | 15/200(7.5%) |
| Bottled water | 0/50(0%) |
| Tap water | 4/50(8%) |
| Underground water | 8/50(16%) |
| River water | 3/50(6%) |
Antibiotic susceptibility profile of the isolated Cronobacter sakazakii strains.
| Antibiotics | Sensitivity of | |
| Sensitive | Resistant | |
| Ampicillin (10 μg) | 0 (0) | 84 (100) |
| Amoxicillin (25 μg) | 0 (0) | 84 (100) |
| Ampicillin/sulbactam (20 μg) | 0 (0) | 84 (100) |
| Tetracycline (30 μg) | 84 (100) | 0 (0) |
| Gentamycin (10 μg) | 80 (95.2) | 4 (4.7) |
| Erythromycin (15 μg) | 79 (94) | 15 (17.8) |
| Clindamycin (2 μg) | 0 (0) | 84 (100) |
| Tobramycin (10 μg) | 81 (96.4) | 3 (3.5) |
| Chloramphenicol (30 μg) | 84 (100) | 0 (0) |
| Cefoxitin (30 μg) | 84 (100) | 0 (0) |
| Cefuroxime (30 μg) | 0 (0) | 84 (100) |
| Cephalexin (10 μg) | 0 (0) | 84 (100) |
| Cephalothin (30 μg) | 0 (0) | 84 (100) |
| Cefadroxil (30 μg) | 12 (14.2) | 72 (84.5) |
| Cefoperazone (75 μg) | 84 (100) | 0 (0) |
| Ceftriaxone (30 μg) | 84 (100) | 0 (0) |
| Ciprofloxacin (5 μg) | 84 (100) | 0 (0) |
| Norfloxacin (10 μg) | 84 (100) | 0 (0) |
| Levofloxacin (10 μg) | 84 (100) | 0 (0) |
| Imipenem (10 μg) | 84 (100) | 0 (0) |
Biofilm formation by isolated Cronobacter sakazakii.
| Source | Strong biofilm producer (OD570 > 2) | Moderate biofilm producer (1 < OD570 > 2) | Weak biofilm producer (0.5 < OD570 > 1) | NO biofilm formation (OD570 < 0.5) |
| Cases of neonatal sepsis ( | 7 | 5 | – | – |
| PIF samples ( | 37 | 33 | – | – |
| Herbs samples ( | 23 | 23 | – | – |
| Water samples ( | 10 | 5 | – | – |